Related Experiment Video
Updated: May 25, 2026

Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
Published on: July 3, 2025
Protein kinase G may exert pro-degradation inhibition on nitric oxide synthase
1Department of Pharmacology, Lagos State University College of Medicine, Lagos, Nigeria. theresaadebola@yahoo.com
Abstract:
Nitric oxide synthase (NOS) is regulated by protein-protein interactions. We had earlier shown that PKG inhibits activated NOS in endothelial cells and speculated that PKG phosphorylation of NOS terminates its activity. The present work examines if PKG activation increases breakdown of NOS. Diamino-fluorescein fluorescence spectrometry of real time NO production was used to establish that isolated ovine lung microvascular endothelial cells responded to PKG modulation as previously reported. Fluorescence activated cell sorter (FACS) analysis was used to establish that 8-Br-cGMP, a PKG activator, caused carboxy terminal deletion on NOS, a sign of degradation. Western blot analysis was used to investigate NOS fragments in control and 5 min 8-Br-cGMP treated cells. PKG activator 8-Br-cGMP, at 20 nM, 200 nM, and 2 μM, decreased nitric oxide production in a dose dependent manner (p<0.05 in all cases). PKG inhibitors: 100 μM Rp-8-Br-PET-cGMPS, 50 nM Rp-8-pCPT-cGMPS, or 4 μM Rp-8-Br-cGMPS Na significantly increased NO production (p<0.05) showing that PKG normally inhibits basal NO production. 8-Br-cGMP (100 nM) abrogated the elevation in NO production produced by the PKG inhibitors. FACS analysis revealed that PKG decreased NOS carboxy terminal labeling. Western blot analysis revealed that 8-Br-cGMP increased N-terminal serine-116 phosphorylated NOS fragments of molecular weights of about 60, 50 and 35 kDa. PKG may be a post-activation inhibitor of NOS, possibly important for the degradation of the spent enzyme.
Insights
Protein kinase G (PKG) activation promotes the degradation of nitric oxide synthase (NOS) in endothelial cells. This study reveals that PKG triggers NOS carboxy-terminal deletion and fragmentation, suggesting a role in enzyme clearance after activation.
Area of Science:
- Biochemistry
- Cell Biology
- Physiology
Background:
- Nitric oxide synthase (NOS) activity is regulated by protein-protein interactions.
- Protein kinase G (PKG) is known to inhibit activated NOS in endothelial cells.
- Previous work suggested PKG phosphorylation terminates NOS activity.
Purpose of the Study:
- To investigate whether PKG activation increases the breakdown of NOS.
- To elucidate the mechanism by which PKG modulates NOS activity and stability.
Main Methods:
- Diamino-fluorescein fluorescence spectrometry for real-time nitric oxide (NO) production measurement.
- Fluorescence-activated cell sorting (FACS) analysis for NOS carboxy-terminal labeling.
- Western blot analysis to detect NOS fragments and phosphorylation.
Main Results:
- PKG activator 8-Br-cGMP dose-dependently decreased NO production.
- PKG inhibitors increased basal NO production, which was abrogated by 8-Br-cGMP.
- FACS and Western blot showed 8-Br-cGMP induced NOS carboxy-terminal deletion and N-terminal phosphorylation, generating 60, 50, and 35 kDa fragments.
Conclusions:
- PKG activation leads to NOS degradation, indicated by carboxy-terminal deletion and fragmentation.
- PKG acts as a post-activation inhibitor of NOS, potentially facilitating the clearance of the enzyme.
- This degradation pathway may be crucial for regulating NOS function in endothelial cells.
Related Concept Videos
Nitric Oxide Signaling Pathway
Amplifying Signals via Enzymatic Cascade
GPCR Desensitization
Antihypertensive Drugs: Vasodilators
GPCRs Regulate Adenylyl Cylase Activity
Two...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

